Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig - PubMed
- ️Thu Jan 01 1998
Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig
J Bowes et al. Eur J Pharmacol. 1998.
Abstract
The effect of the Poly (adenosine 5'-diphosphate ribose) synthetase (PARS) inhibitor 3-aminobenzamide on (i) infarct size caused by regional myocardial ischaemia (60 min) and reperfusion (3 h) in the anaesthetised pig, and (ii) on the cell injury/necrosis of human cardiomyoblasts caused by hydrogen peroxide (3 mM) was investigated. Regional myocardial ischaemia and reperfusion resulted in an infarct size of 66+/-3% of the area at risk, which was reduced by 3-aminobenzamide (to 44+/-2%, n=6), but not 3-aminobenzoic acid (66+/-5%, n=4). 3-aminobenzamide also reduced the postischaemic contractile dysfunction. 3-aminobenzamide, but not 3-aminobenzoic acid, abolished the increase in PARS activity as well as the cell injury/necrosis caused by hydrogen peroxide in the cardiomyoblasts. In conclusion, the PARS inhibitor 3-aminobenzamide reduces myocardial reperfusion injury in the pig, and attenuates the cell injury and death associated with oxidant stress in human cardiomyoblasts. We propose that the activation of PARS plays an important role in the injury associated with oxidant stress of the heart.
Similar articles
-
Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress.
Bowes J, McDonald MC, Piper J, Thiemermann C. Bowes J, et al. Cardiovasc Res. 1999 Jan;41(1):126-34. doi: 10.1016/s0008-6363(98)00221-1. Cardiovasc Res. 1999. PMID: 10325960
-
Zingarelli B, Cuzzocrea S, Zsengellér Z, Salzman AL, Szabó C. Zingarelli B, et al. Cardiovasc Res. 1997 Nov;36(2):205-15. doi: 10.1016/s0008-6363(97)00137-5. Cardiovasc Res. 1997. PMID: 9463632
-
Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
Liaudet L, Yang Z, Al-Affar EB, Szabó C. Liaudet L, et al. Mol Med. 2001 Jun;7(6):406-17. Mol Med. 2001. PMID: 11474134 Free PMC article.
-
Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
Szabó C, Dawson VL. Szabó C, et al. Trends Pharmacol Sci. 1998 Jul;19(7):287-98. doi: 10.1016/s0165-6147(98)01193-6. Trends Pharmacol Sci. 1998. PMID: 9703762 Review.
-
Slice me nice: DNAzymes get close to the heart.
Kelley R, Patterson C. Kelley R, et al. J Thromb Haemost. 2006 Jul;4(7):1476-8. doi: 10.1111/j.1538-7836.2006.02034.x. J Thromb Haemost. 2006. PMID: 16839340 Review. No abstract available.
Cited by
-
Tanonaka K, Toga W, Takahashi M, Kawana K, Miyamoto Y, Yoshida H, Takeo S. Tanonaka K, et al. Mol Cell Biochem. 2003 Jun;248(1-2):149-55. doi: 10.1023/a:1024192403758. Mol Cell Biochem. 2003. PMID: 12870667
-
Pacher P, Szabó C. Pacher P, et al. Cardiovasc Drug Rev. 2007 Fall;25(3):235-60. doi: 10.1111/j.1527-3466.2007.00018.x. Cardiovasc Drug Rev. 2007. PMID: 17919258 Free PMC article. Review.
-
Pieper AA, Blackshaw S, Clements EE, Brat DJ, Krug DK, White AJ, Pinto-Garcia P, Favit A, Conover JR, Snyder SH, Verma A. Pieper AA, et al. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1845-50. doi: 10.1073/pnas.97.4.1845. Proc Natl Acad Sci U S A. 2000. PMID: 10677544 Free PMC article.
-
Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.
Curtin NJ, Szabo C. Curtin NJ, et al. Mol Aspects Med. 2013 Dec;34(6):1217-56. doi: 10.1016/j.mam.2013.01.006. Epub 2013 Jan 29. Mol Aspects Med. 2013. PMID: 23370117 Free PMC article. Review.
-
Liaudet L, Szabó E, Timashpolsky L, Virág L, Cziráki A, Szabó C. Liaudet L, et al. Br J Pharmacol. 2001 Aug;133(8):1424-30. doi: 10.1038/sj.bjp.0704185. Br J Pharmacol. 2001. PMID: 11498530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous